Article info

Download PDFPDF

Safety and efficacy of self-administered inhaled loxapine (ADASUVE) in agitated patients outside the hospital setting: protocol for a phase IV, single-arm, open-label trial

Authors

  1. Correspondence to Dr Emilio Gil; egil{at}ferrer.com
View Full Text

Citation

Gil E, Garcia- Alonso F, Boldeanu A On behalf of Loxapine Inhaled Home Use study investigator’s team, et al
Safety and efficacy of self-administered inhaled loxapine (ADASUVE) in agitated patients outside the hospital setting: protocol for a phase IV, single-arm, open-label trial

Publication history

  • Received October 27, 2017
  • Revised January 26, 2018
  • Accepted March 1, 2018
  • First published October 2, 2018.
Online issue publication 
October 02, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.